Dror Bashan | President and Chief Executive Officer |
Eyal Rubin | Senior Vice President and Chief Financial Officer |
Good day. And welcome to the Protalix Biotherapeutics Third Quarter 2019 Earnings Call. Today's call is being recorded. At this time, I'd like to turn the conference over to [Mani Kasi] of LifeSci Advisors. Please go ahead.